This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Allen, W. L. Articles by Johnston, P. G. Search for Related Content PubMed PubMed Citation Articles by Allen, W. L. Articles by Johnston, P. G.

Research Articles: Therapeutics, Targets, and Development

The role of spermidine/spermine N¹-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells

¹ Department of Oncology, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland and ² Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, Baltimore, Maryland

Requests for reprints: Patrick G. Johnston, Department of Oncology, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast City Hospital, University Floor, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, Northern Ireland. Phone: 44-28-90263911; Fax: 44-28-90263744. E-mail: oncology{at}qub.ac.uk

Abstract

Polyamines have been shown to play a role in the growth and survival of several solid tumors, including colorectal cancer. We identified the polyamine catabolic enzyme spermidine/spermine N¹-acetyltransferase (SSAT) as being one of the most highly inducible genes in two DNA microarray screens to identify novel determinants of response to chemotherapeutic agents in colorectal cancer. SSAT was shown to be inducible in response to 5-fluorouracil (5-FU) or oxaliplatin in parental and drug-resistant HCT116 cell lines. It was also shown that SSAT mRNA was up-regulated in response to 5-FU or oxaliplatin in a panel of six colorectal cancer cell lines. The polyamine analogue N¹,N¹¹-diethylnorspermine (DENSpm) depletes polyamine pools and potently induces SSAT. We evaluated the effect of combining DENSpm with chemotherapeutic agents in HCT116 p53^+/+ cells and in HCT116 drug-resistant daughter cell lines. Western blot analyses showed that SSAT protein expression was dramatically enhanced when DENSpm was combined with oxaliplatin or 5-FU in HCT116 p53^+/+ cells. Using cell viability assays and flow cytometry, synergistic induction of cell death was observed following cotreatment of HCT116 p53^+/+ cells with DENSpm and each chemotherapeutic agent. Of note, this combined therapy increased the chemosensitivity of cells rendered resistant to each of these chemotherapeutic agents. Small interfering RNA–mediated down-regulation of SSAT resulted in loss of synergy between DENSpm and these agents. These results show that SSAT plays an important role in regulating cell death following combined cytotoxic drug and DENSpm treatment. Furthermore, DENSpm sensitizes both sensitive and resistant cells to chemotherapeutic agents. Taken together, these results suggest that SSAT may be an important target for therapeutic intervention in colorectal cancer. [Mol Cancer Ther 2007;6(1):128–37]

Grant support: Cancer Research UK, Action Cancer, Research and Development Office, Northern Ireland; Department for Employment and Learning, Northern Ireland; Ulster Cancer Foundation; and NIH grant CA51085.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Note: W.A. Allen and E.G. McLean contributed equally to this work.

³ Detailed experimental protocols and raw expression data are available at http://www.ebi.ac.uk/arrayexpress/ (accession no. E-MEXP-390).

Received 5/23/06; revised 10/18/06; accepted 11/20/06.

This article has been cited by other articles:

				W. L. Allen, V. M. Coyle, P. V. Jithesh, I. Proutski, L. Stevenson, C. Fenning, D. B. Longley, R. H. Wilson, M. Gordon, H.-J. Lenz, et al. Clinical Determinants of Response to Irinotecan-Based Therapy Derived from Cell Line Models Clin. Cancer Res., October 15, 2008; 14(20): 6647 - 6655. [Abstract] [Full Text] [PDF]

				A. E. Pegg Spermidine/spermine-N1-acetyltransferase: a key metabolic regulator Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E995 - E1010. [Abstract] [Full Text] [PDF]

				J. H. Baek, Y. V. Liu, K. R. McDonald, J. B. Wesley, H. Zhang, and G. L. Semenza Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1{alpha} (HIF-1{alpha}) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1{alpha} J. Biol. Chem., November 16, 2007; 282(46): 33358 - 33366. [Abstract] [Full Text] [PDF]